1. Short title This Act may be cited as the Advancing Education on Biosimilars Act of 2019 . 2. Education on biological products (a) In general Subpart 1 of part F of title III of the Public Health Service Act ( 42 U.S.C. 262 et seq.) is amended by adding at the end the following: 352A. Education on biological products (a) Internet website (1) In general The Secretary shall establish, maintain, and operate an internet website consisting of educational materials regarding the meaning and use of biosimilar biological products and interchangeable biological products. (2) Format The educational materials provided under paragraph (1)— (A) may be in the form of webinars, continuing medical education modules, videos, fact sheets, infographics, stakeholder toolkits, or other formats, as the Secretary determines appropriate; (B) shall be presented in a manner, using simple terminology, that is easily comprehended by appropriate target audiences, including accounting, to the extent practicable, for varying levels of health literacy among patients and caregivers; (C) shall be tailored for the unique needs of appropriate target audiences, including— (i) health care providers with prescribing authority or dispensing authority under applicable State law, including physicians, nurses, nurse practitioners, physician assistants, pharmacists, and pharmacy technicians; and (ii) patients and caregivers; and (D) may, as appropriate, be additionally tailored to health care providers practicing in specialties in which biological products commonly are prescribed or to patient populations to whom biological products commonly are prescribed or administered. (3) Content Educational materials provided under paragraph (1) shall include explanations of— (A) key statutory and regulatory definitions, including the definitions of the terms biosimilar and interchangeable , and clarification that an interchangeable product is not superior in quality to a biosimilar biological product